Zoetis Inc. (LON:0M3Q)

Market Cap	40.28B
Revenue (ttm)	6.99B
Net Income (ttm)	1.97B
Shares Out	n/a
EPS (ttm)	4.42
PE Ratio	20.42
Forward PE	18.60
Dividend	1.53 (1.24%)
Ex-Dividend Date	Oct 31, 2025

Volume	817
Average Volume	4,636
Open	122.56
Previous Close	123.67
Day's Range	122.32 - 125.14
52-Week Range	114.00 - 179.11
Beta	0.97
RSI	50.64
Earnings Date	Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1950
• Employees: 13,800
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M3Q

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD